167 related articles for article (PubMed ID: 9089745)
1. Cutaneous infiltration by leukemic cells in acute promyelocytic leukemia of a child after treatment with all-trans retinoic acid.
Kishimoto S; Ishii E; Murakami Y; Takeshita M; Watanabe M; Sakai R; Miyazaki S
Pediatr Hematol Oncol; 1997; 14(2):169-75. PubMed ID: 9089745
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of extramedullary acute promyelocytic leukemia by all-trans-retinoic acid.
Lederman CA; Weisberger J; Seiter K; Feldman EJ
Leuk Lymphoma; 1995 Jun; 18(1-2):189-93. PubMed ID: 8580825
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of semiquantitative reverse transcriptase-polymerase chain reaction assay of PML/retinoic acid receptor alpha mRNA and in vitro differentiation assay as prognostic prediction in acute promyelocytic leukemia treated with all-trans retinoic acid.
Iwakiri R; Inokuchi K; Dan K; Wakabayashi I
Nihon Ika Daigaku Zasshi; 1996 Aug; 63(4):259-67. PubMed ID: 8810554
[TBL] [Abstract][Full Text] [Related]
4. Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acid.
Giralt S; O'Brien S; Weeks E; Luna M; Kantarjian H
Leuk Lymphoma; 1994 Aug; 14(5-6):453-6. PubMed ID: 7812204
[TBL] [Abstract][Full Text] [Related]
5. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
Robak T
Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
[TBL] [Abstract][Full Text] [Related]
6. [Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid].
Itoh K; Gotoh W; Yagasaki F; Itoh Y; Kawai N; Matsuda A; Tominaga K; Kusumoto S; Ino H; Murohashi I; Jinnai I; Takeuchi H; Bessho M; Hirashima K
Rinsho Ketsueki; 1998 Mar; 39(3):221-6. PubMed ID: 9577647
[TBL] [Abstract][Full Text] [Related]
7. Skin infiltration in acute promyelocytic leukemia.
Nagao K; Kikuchi A; Kawai Y; Kizaki M; Ikeda Y; Nishikawa T
Dermatology; 1997; 194(2):168-71. PubMed ID: 9094468
[TBL] [Abstract][Full Text] [Related]
8. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
9. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
[TBL] [Abstract][Full Text] [Related]
10. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
11. Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies.
Tsimberidou AM; Estey E; Whitman GJ; Dryden MJ; Ratnam S; Pierce S; Faderl S; Giles F; Kantarjian HM; Garcia-Manero G
Leuk Res; 2004 Sep; 28(9):991-4. PubMed ID: 15234578
[TBL] [Abstract][Full Text] [Related]
12. Molecular monitoring of minimal residual disease in acute promyelocytic leukemia by the polymerase chain reaction assay for the PML/RAR alpha (retinoic acid receptor-alpha) fusion transcript in patients treated with all-trans retinoic acid followed by chemotherapy.
Nemet D; Grahovac B; Labar B; Mrsić M; Radman I; Bogdanić V; Hitrec V; Zaher D; Aurer I; Sertić D
Haematologica; 1995; 80(3):238-40. PubMed ID: 7672716
[TBL] [Abstract][Full Text] [Related]
13. [A study on the relationship between morphology and gene heterogeneity in acute promyelocytic leukemia].
Xiong S; Chen Z; Huang W
Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):165-8. PubMed ID: 7648936
[TBL] [Abstract][Full Text] [Related]
14. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).
Asou N; Adachi K; Tamura U; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Akiyama H; Tsubaki K; Saito K; Kuriyama K; Oh H; Kitano K; Miyawaki S; Takeyama U; Yamada O; Nishikawa K; Takahashi M; Matsuda S; Ohtake H; Ohno R
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S65-71. PubMed ID: 11587370
[TBL] [Abstract][Full Text] [Related]
15. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
Chen Z; Chen SJ; Wang ZY
C R Acad Sci III; 1994 Dec; 317(12):1135-41. PubMed ID: 7697468
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
18. All-trans-retinoic acid (ATRA): pediatric acute promyelocytic leukemia.
Bapna A; Nair R; Tapan KS; Nair CN; Kadam P; Gladstone B; Advani SH
Pediatr Hematol Oncol; 1998; 15(3):243-8. PubMed ID: 9615322
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
20. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
